Clinical Trials
11 trialsNCT06848348 2026-05-29
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Dogwood Therapeutics Inc.
Phase 2 Recruiting
NCT07109817 2026-05-29
DETOXp
Montefiore Medical Center
Phase 2 Recruiting
NCT05458284 2025-08-27
The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT06135493 2025-04-24
Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients
Future University in Egypt
Phase 2 Completed
NCT05689359 2024-03-08
Evaluation of Hydroxychloroquine to Prevent CIPN
University of Arizona
Phase 2 Withdrawn
NCT04675450 2023-06-08
NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy
Conjupro Biotherapeutics, Inc.
Phase 2 Withdrawn
NCT05351021 2023-03-09
Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients
Mansoura University
Phase 2 Completed
NCT04565600 2022-02-14
Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib
Guangdong Provincial People's Hospital
Phase 2 Completed
NCT02297412 2022-01-31
Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel
Academic and Community Cancer Research United
Phase 2 Completed
NCT02795572 2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2 Terminated
NCT02230319 2015-10-01
Prevention of Paclitaxel Neuropathy With Cryotherapy
Medical Oncology & Hematology Associates of Northern Virginia
Phase 2 Unknown